<?xml version="1.0" encoding="utf-8"?>
			<journal>
			<title>Asia Oceania Journal of Nuclear Medicine and Biology</title>
			<title_fa></title_fa>
			<short_title>AOJNMB</short_title>
			<subject>Medical Sciences</subject>
			<web_url>https://aojnmb.mums.ac.ir/</web_url>
			<journal_hbi_system_id>0</journal_hbi_system_id>
			<journal_hbi_system_user></journal_hbi_system_user>
			<journal_id_issn>2322-5718</journal_id_issn>
			<journal_id_issn_online>2322-5726</journal_id_issn_online>
			<journal_id_pii></journal_id_pii>
			<journal_id_doi></journal_id_doi>
			<journal_id_iranmedex></journal_id_iranmedex>
			<journal_id_magiran></journal_id_magiran>
			<journal_id_sid></journal_id_sid>
			<journal_id_nlai></journal_id_nlai>
			<journal_id_science></journal_id_science>
			<language>en</language>
			<pubdate>
				<type>jalali</type>
				<year>0</year>
				<month>0</month>
				<day>1</day>
			</pubdate>
			<pubdate>
				<type>gregorian</type>
				<year>2021</year>
				<month>1</month>
				<day>1</day>
			</pubdate>
			<volume>9</volume>
			<number>1</number>
			<publish_type>online</publish_type>
			<publish_edition>1</publish_edition>
			<article_type>fulltext</article_type>
			<articleset><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Incremental Value of FDG PET/CT in Aggressive High Grade B Cell lymphoma with TdT Expression</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Case report</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[High-grade B-cell lymphoma, an aggressive form of Non-Hodgkin’s Lymphoma, is known as a double or triple hit lymphoma based on the presence of MYC and BCL2 without or with BCL6 genetic rearrangements, respectively. It carries a poorer prognosis, compared to other variants of B-cell lymphoma, and its management also differs which requires more intensive chemotherapy in contrast to the routine regimen. Terminal deoxynucleotidyl transferase (TdT), a marker of immaturity is commonly expressed in B-cell lymphoblastic leukemia or lymphoma (B cell ALL) which is absent in mature forms of B-cell lymphoma. The TdT is expressed in high-grade B-cell lymphoma; therefore, it poses a classification and management dilemma, which should be accurately differentiated from B-cell ALL and mandates molecular analysis. Herein, we report a case of a 52-year-old female with biopsy reported as high-grade B-cell lymphoma with TdT expression. She was referred for Fluor-deoxyglucose (FDG) Positron Emission Tomography-Computed Tomography (PET/CT) scan for staging in the absence of molecular analysis for B-cell ALL. It was diagnosed as lymphoma on FDG PET/CT based on its characteristic findings of extensive extranodal involvement of multiple organs with no significant lymphadenopathy establishing the incremental value of FDG PET/CT scan, which helped the clinician to arrive at a conclusion.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>TdT expression, extranodal B cell lymphoma, FDG PET/CT</keyword>
				<start_page>45</start_page>
				<end_page>50</end_page>
				<web_url>https://aojnmb.mums.ac.ir/article_16764.html</web_url>
			<author_list><author>
				<first_name>NIKITA</first_name>
				<middle_name></middle_name>
				<last_name>SAMPATHIRAO</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>drnikita.srao@gmail.com</email>
				<code>71515</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Nuclear Medicine and PET/CT, Apollo Hospitals, Chennai, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Indirani</first_name>
				<middle_name>M</middle_name>
				<last_name>Muthukrishnan</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>drindinm@gmail.com</email>
				<code>71516</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Medicine and PET/CT, Apollo Hospitals, Chennai, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ann</first_name>
				<middle_name></middle_name>
				<last_name>Kurian</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>drannkurian@gmail.com</email>
				<code>71517</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pathology, Apollo Hospitals, Chennai, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Jaykanth</first_name>
				<middle_name></middle_name>
				<last_name>Amalchandran</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>jaykanthamal@gmail.com</email>
				<code>71518</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Medicine and PET/CT, Apollo Hospitals, Chennai, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Asra</first_name>
				<middle_name></middle_name>
				<last_name>Patel</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>asra_patel@yahoo.co.in</email>
				<code>71519</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Medicine and PET/CT, Apollo Hospitals, Chennai, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>shema</first_name>
				<middle_name></middle_name>
				<last_name>mathew</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mathew.shema@gmail.com</email>
				<code>71520</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Medicine and PET/CT, Apollo Hospitals, Chennai, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Shelley</first_name>
				<middle_name></middle_name>
				<last_name>Simon</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>shelleysimon@rediffmail.com</email>
				<code>71521</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nuclear Medicine and PET/CT, Apollo Hospitals, Chennai, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article>
			</articleset>
			</journal>